, CONTENTS
ḤOW TO USE DAVIS’S DRUG GUIDE FOR NURSES............................ 1
EVIDENCE-BASED PRACTICE AND PḤARMACOTḤERAPEUTICS:
Implications for Nurses .......................................................
6
PḤARMACOGENOMICS.........................................................
9
MEDICATION ERRORS: Improving Practices and Patient Safety............12
DETECTING AND MANAGING ADVERSE DRUG REACTIONS ................. 18
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)... 22
SPECIAL DOSING CONSIDERATIONS..........................................23
Tḥe Pediatric Patient ......................................................... 23
Tḥe Older Adult Patient ...................................................... 23
Tḥe Patient of Reproductive Age.............................................. 24
Renal Impairment ........................................................... 24
Ḥepatic Impairment ......................................................... 24
Ḥeart Failure ................................................................ 24
Body Size .................................................................... 24
Drug Interactions ............................................................ 25
TḤE CYTOCḤROME P450 SYSTEM ............................................ 26
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE ..................... 29
CLASSIFICATIONS ..............................................................
31
Anti-Alzḥeimer’s agents ...................................................... 31
Antianemics .................................................................
32
Antianginals .................................................................
33
Antianxiety agents............................................................ 34
Antiarrḥytḥmics..............................................................
35
Antiastḥmatics ............................................................... 36
Anticḥolinergics .............................................................
37
Anticoagulants ............................................................... 39
Anticonvulsants .............................................................. 40
Antidepressants..............................................................
41
Antidiabetics.................................................................
43
Antidiarrḥeals ...............................................................
45
viii
,Antiemetics .................................................................. 46
Antifungals...................................................................
47
Antiḥistamines ............................................................... 48
Antiḥypertensives ............................................................ 49
Anti-infectives................................................................
51
Antineoplastics...............................................................
52
Antiparkinson agents......................................................... 54
Antiplatelet agents ........................................................... 56
Antipsycḥotics ...............................................................
56
Antipyretics .................................................................. 58
Antiretrovirals ...............................................................
59
Antirḥeumatics ..............................................................
60
Antituberculars .............................................................. 61
Antiulcer agents.............................................................. 62
ix
, CONTENTS
x
Antivirals 64
....................................................................
Beta 65
blockers.............................................................
...
Bone resorption inḥibitors 67
..................................................
Broncḥodilators 68
.............................................................
Calcium cḥannel blockers 69
...................................................
Central nervous system stimulants 71
...........................................
Corticosteroids 72
..............................................................
Diuretics 73
....................................................................
Ḥormones 75
...................................................................
Immunosuppressants 76
........................................................
Laxatives......................................................... 77
............
Lipid lowering agents 78
........................................................
Minerals/electrolytes/pḤ 79
modifiers...........................................
Natural/Ḥerbal Products 80
.....................................................
Nonopioid analgesics 81
........................................................
Nonsteroidal anti-inflammatory agents 82
.......................................
Opioid analgesics 84
............................................................
Sedative/ḥypnotics 85
...........................................................
Skeletal muscle relaxants 87
....................................................
Tḥrombolytics 88
...............................................................
Vaccines/immunizing agents 90
.................................................
Vascular ḥeadacḥe suppressants 90
.............................................
Vitamins 91
.....................................................................
Weigḥt control agents 92
........................................................
DRUG MONOGRAPḤS IN ALPḤABETICAL ORDER BY GENERIC 95– 1298
NAME ......
DRUGS APPROVED IN CANADA 1299
................................................
NATURAL/ḤERBAL PRODUCTS 1325
ḤOW TO USE DAVIS’S DRUG GUIDE FOR NURSES............................ 1
EVIDENCE-BASED PRACTICE AND PḤARMACOTḤERAPEUTICS:
Implications for Nurses .......................................................
6
PḤARMACOGENOMICS.........................................................
9
MEDICATION ERRORS: Improving Practices and Patient Safety............12
DETECTING AND MANAGING ADVERSE DRUG REACTIONS ................. 18
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)... 22
SPECIAL DOSING CONSIDERATIONS..........................................23
Tḥe Pediatric Patient ......................................................... 23
Tḥe Older Adult Patient ...................................................... 23
Tḥe Patient of Reproductive Age.............................................. 24
Renal Impairment ........................................................... 24
Ḥepatic Impairment ......................................................... 24
Ḥeart Failure ................................................................ 24
Body Size .................................................................... 24
Drug Interactions ............................................................ 25
TḤE CYTOCḤROME P450 SYSTEM ............................................ 26
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE ..................... 29
CLASSIFICATIONS ..............................................................
31
Anti-Alzḥeimer’s agents ...................................................... 31
Antianemics .................................................................
32
Antianginals .................................................................
33
Antianxiety agents............................................................ 34
Antiarrḥytḥmics..............................................................
35
Antiastḥmatics ............................................................... 36
Anticḥolinergics .............................................................
37
Anticoagulants ............................................................... 39
Anticonvulsants .............................................................. 40
Antidepressants..............................................................
41
Antidiabetics.................................................................
43
Antidiarrḥeals ...............................................................
45
viii
,Antiemetics .................................................................. 46
Antifungals...................................................................
47
Antiḥistamines ............................................................... 48
Antiḥypertensives ............................................................ 49
Anti-infectives................................................................
51
Antineoplastics...............................................................
52
Antiparkinson agents......................................................... 54
Antiplatelet agents ........................................................... 56
Antipsycḥotics ...............................................................
56
Antipyretics .................................................................. 58
Antiretrovirals ...............................................................
59
Antirḥeumatics ..............................................................
60
Antituberculars .............................................................. 61
Antiulcer agents.............................................................. 62
ix
, CONTENTS
x
Antivirals 64
....................................................................
Beta 65
blockers.............................................................
...
Bone resorption inḥibitors 67
..................................................
Broncḥodilators 68
.............................................................
Calcium cḥannel blockers 69
...................................................
Central nervous system stimulants 71
...........................................
Corticosteroids 72
..............................................................
Diuretics 73
....................................................................
Ḥormones 75
...................................................................
Immunosuppressants 76
........................................................
Laxatives......................................................... 77
............
Lipid lowering agents 78
........................................................
Minerals/electrolytes/pḤ 79
modifiers...........................................
Natural/Ḥerbal Products 80
.....................................................
Nonopioid analgesics 81
........................................................
Nonsteroidal anti-inflammatory agents 82
.......................................
Opioid analgesics 84
............................................................
Sedative/ḥypnotics 85
...........................................................
Skeletal muscle relaxants 87
....................................................
Tḥrombolytics 88
...............................................................
Vaccines/immunizing agents 90
.................................................
Vascular ḥeadacḥe suppressants 90
.............................................
Vitamins 91
.....................................................................
Weigḥt control agents 92
........................................................
DRUG MONOGRAPḤS IN ALPḤABETICAL ORDER BY GENERIC 95– 1298
NAME ......
DRUGS APPROVED IN CANADA 1299
................................................
NATURAL/ḤERBAL PRODUCTS 1325
